BIOV (BIOV) News
Follow BIOV (BIOV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BioVersys to present at H.C. Wainwright 28th Global Investment Conference
BioVersys AG will present at the H.C. Wainwright 28th Annual Global Investment Conference in Basel, Switzerland on September 3, 2026 at 7:00am CEST.
EQUITY | Sep 03, 2026, 05:01 AM UTC
M
BioVersys BV100 gets US FDA Fast-Track Designation
BioVersys AG said the US FDA granted Fast-Track Designation for BV100. The company framed the designation as support for an urgent need for novel and innovative antimicrobials to treat serious infections.
REGULATION | Sep 02, 2026, 05:02 AM UTC